600223.SH
Lushang Freda Pharmaceutical Co., Ltd.
SSE · Healthcare · Real Estate - Development · CN
CNY 5.55
+1.28%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- 28.34x
- P/E 2027E
- 23.61x
- P/E 2028E
- 19.68x
- P/S forward
- —
Trailing multiples
Trailing twelve months
- P/E TTM
- 30.05x
- PEG TTM
- 0.51x
- Price / book
- 1.34x
- Price / sales
- 1.52x
- Price / cash flow
- 15.39x
Enterprise value
- Enterprise value
- CNY 3.6B
- EV / sales
- 0.98x
- EV / EBITDA
- 8.98x
- EV / EBIT
- 14.00x
- Market cap
- CNY 5.6B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Mar 1, 2026